APL-1202 enhances anti-tumor immune response through induction of cellular stress signaling and immunogenic cell death pathway in cancer cells

被引:0
|
作者
Bam, Rakesh
Guan, Jingmin
Vellichirammal, Neetha Nanoth
Manohar, Murli
Mulholland, David
Sfakianos, John
Sun, Qiaoling
Yi, Zuoan
Chen, Alice
机构
关键词
D O I
10.1158/1538-7445.AM2024-5272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5272
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
    Mardi, Amirhossein
    Shirokova, Anastasia, V
    Mohammed, Rebar N.
    Keshavarz, Ali
    Zekiy, Angelina O.
    Thangavelu, Lakshmi
    Mohamad, Talar Ahmad Merza
    Marofi, Faroogh
    Shomali, Navid
    Zamani, Amir
    Akbari, Morteza
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [32] Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response
    Sarkar, Koustav
    Goswami, Shyamal
    Roy, Soumyabrata
    Mallick, Atanu
    Chakraborty, Krishnendu
    Bose, Anamika
    Baral, Rathindranath
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (08) : 865 - 874
  • [33] Flavonoid Group of Smilax glabra Roxb. Regulates the Anti-Tumor Immune Response Through the STAT3/HIF-1 Signaling Pathway
    Guo, Yingxue
    Mao, Weiye
    Jin, Lu
    Xia, Linying
    Huang, Jie
    Liu, Xia
    Ni, Ping
    Shou, Qiyang
    Fu, Huiying
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] Curcumin potentiates the galbanic acid-induced anti-tumor effect in non-small cell lung cancer cells through inhibiting Akt/mTOR signaling pathway
    Zhang, Qian
    Qiao, Haowen
    Wu, Dedong
    Lu, Hui
    Liu, Liying
    Sang, Xueyu
    Li, Daifeng
    Zhou, Yu
    LIFE SCIENCES, 2019, 239
  • [35] CHKing melanoma: CHK1 inhibitor plus low dose hydroxyurea triggers immunogenic cell death and immunostimulatory cytokine expression to drive an anti-tumor immune response.
    Gabrielli, Brian G.
    Proctor, Martina
    Cruz, Jazmina Gonzalez
    Zeng, Bijun
    Dolcetti, Riccardo
    Keane, Colm
    Haass, Nikolas
    Wells, James
    CANCER RESEARCH, 2021, 81 (13)
  • [36] Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens
    Liu, Xinli
    Song, Na
    Liu, Yu
    Liu, Yang
    Li, Jijia
    Ding, Jianqiao
    Tong, Zhuang
    CELLULAR IMMUNOLOGY, 2015, 295 (02) : 77 - 82
  • [37] Targeting vasoactive intestinal peptide receptor signaling enhances T-cell mediated anti-tumor response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
    Passang, Tenzin
    Ravindranathan, Sruthi
    Li, Jian-Ming
    Wang, Shuhua
    Ware, Michael Brandon
    Zhang, Hanwen
    Lesinski, Gregory B.
    Waller, Edmund K.
    CANCER RESEARCH, 2022, 82 (22) : 115 - 116
  • [38] Initial IL7R signaling regulate the induction of effector CD8+T cells and subsequent anti-tumor immune response in lymphopenic host
    Suzuki, Toshihiro
    Kishimoto, Hidehiro
    Abe, Ryo
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [39] Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells
    Kang, Ji In
    Hong, Ji-Young
    Lee, Hye-Jung
    Bae, Song Yi
    Jung, Cholomi
    Park, Hyen Joo
    Lee, Sang Kook
    PLOS ONE, 2015, 10 (12):
  • [40] Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer
    Yuan Jiang
    Yueyuan Zheng
    Yuan-Wei Zhang
    Shuai Kong
    Jinxiu Dong
    Fei Wang
    Benjamin Ziman
    Sigal Gery
    Jia-Jie Hao
    Dan Zhou
    Jianian Zhou
    Allen S. Ho
    Uttam K. Sinha
    Jian Chen
    Shuo Zhang
    Chuntong Yin
    Dan-Dan Wei
    Masaharu Hazawa
    Huaguang Pan
    Zhihao Lu
    Wen-Qiang Wei
    Ming-Rong Wang
    H. Phillip Koeffler
    De-Chen Lin
    Yan-Yi Jiang
    Nature Communications, 15